What is Rhythm Pharmaceuticals, Inc.'s revenue?

Rhythm Pharmaceuticals, Inc. (RYTM) reported revenue of $60.11M in Q1 2026.

How has Rhythm Pharmaceuticals, Inc.'s revenue changed year-over-year?

Rhythm Pharmaceuticals, Inc.'s revenue increased by 83.8% year-over-year, from $32.7M to $60.11M.

What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s revenue?

Over 2 years (2022 to 2025), Rhythm Pharmaceuticals, Inc.'s revenue has grown at a 183.3% compound annual growth rate (CAGR), from $23.64M to $189.76M.

Rhythm Pharmaceuticals, Inc. RYTM Revenue

Revenue at other companies

Henry ScheinHSIC

$3.37B+6.3%

CSXCSX

$3.48B+1.7%

Ionis PharmaceuticalsIONS

$246.09M+87.0%

SBA CommunicationsSBAC

$47.29M-1.6%

Loar HoldingsLOAR

$9.7M+48.1%

Armstrong World IndustriesAWI

$382.9M+12.8%

Other financials

Income statement

See full

Revenue$60.1M+83.8%

Gross profit$53.0M+82.3%

Operating income-$52.4M-11.4%

Net income-$55.6M-12.4%

EPS (diluted)-$0.83-2.5%

Balance sheet

See full

Cash & equivalents$62.1M-41.4%

Total debt$112.3M-1.1%

Total equity$122.9M+549%

Total assets$442.3M+14.4%

Cash flow

See full

Operating cash flow-$44.2M-9.5%

CapEx$238.3K—

Free cash flow-$29.2M-2.4%

Valuation

See full

Market cap$6.64B+77.3%

Enterprise value$6.69B+78.4%

P/S30.6×+3.2×

Profitability

See full

Gross margin89.4%-0.2pp

Operating margin-90.9%-19.8pp

Net margin-93.3%-18.2pp

FCF margin-61.5%-14.1pp

Returns & leverage

See full

Return on equity-285.8%-68.9pp

Debt / equity0.9×-5.1×

Current ratio4.2×+0.9×

Where this comes from

Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rhythm Pharmaceuticals, Inc.'s revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rhythm Pharmaceuticals, Inc.'s revenue?: Rhythm Pharmaceuticals, Inc. (RYTM) reported revenue of $60.11M in Q1 2026.
How has Rhythm Pharmaceuticals, Inc.'s revenue changed year-over-year?: Rhythm Pharmaceuticals, Inc.'s revenue increased by 83.8% year-over-year, from $32.7M to $60.11M.
What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s revenue?: Over 2 years (2022 to 2025), Rhythm Pharmaceuticals, Inc.'s revenue has grown at a 183.3% compound annual growth rate (CAGR), from $23.64M to $189.76M.